Phase II Trial on the Feasibility of Single-Dose Intraoperative Intraperitoneal Carboplatin in Advanced Epithelial Ovarian Cancer Following Optimal Cytoreductive Surgery
Sign Up to like & getrecommendations! Published in 2020 at "Indian Journal of Surgical Oncology"
DOI: 10.1007/s13193-020-01197-1
Abstract: To evaluate the feasibility administering single-dose intraoperative intraperitoneal carboplatin (IP) in advanced epithelial ovarian cancer (EOC) after optimal primary or interval debulking surgery. A phase II non-randomized prospective study conducted at a regional cancer institute… read more here.
Keywords: epithelial ovarian; dose intraoperative; carboplatin; cancer ... See more keywords